Biodesix, Inc. (BDSX)
NASDAQ: BDSX · IEX Real-Time Price · USD
1.770
0.00 (0.00%)
Jul 22, 2024, 9:39 AM EDT - Market open
Biodesix Employees
Biodesix had 217 employees as of December 31, 2023. The number of employees decreased by 28 or -11.43% compared to the previous year.
Employees
217
Change (1Y)
-28
Growth (1Y)
-11.43%
Revenue / Employee
$252,760
Profits / Employee
-$216,857
Market Cap
202.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 217 | -28 | -11.43% |
| Dec 31, 2022 | 245 | 27 | 12.39% |
| Dec 31, 2021 | 218 | 18 | 9.00% |
| Dec 31, 2020 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| bluebird bio | 323 |
| Personalis | 225 |
| CVRx, Inc. | 200 |
| Genfit | 159 |
| Caribou Biosciences | 158 |
| Shattuck Labs | 75 |
| Renovaro Biosciences | 12 |
BDSX News
- 4 weeks ago - Biodesix Named to Inc. Magazine's 2024 “Best Workplaces” - Business Wire
- 7 weeks ago - Biodesix to Participate in Two Investor Conferences in June - Business Wire
- 2 months ago - Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting - Business Wire
- 2 months ago - Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management - Business Wire
- 2 months ago - Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference - Business Wire
- 3 months ago - Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024 - Business Wire
- 3 months ago - Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting - Business Wire
- 3 months ago - Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement - Business Wire